NoBACZ Healthcare, a University of Cambridge spinout, secured £4.8 million in funding to advance its innovative 'liquid bandage' technology for treating wounds in livestock and horses.

Target Information

NoBACZ Healthcare is a University of Cambridge spinout dedicated to revolutionizing the treatment of wounds and lesions in horses and livestock through innovative technology. The company has successfully developed a patented 'liquid bandage' that provides an alternative to traditional antibiotic treatments, which often fall short in agricultural settings.

Founded by Dr. Jonathan Powell and Dr. Nuno Faria, NoBACZ emerged from research at the University of Cambridge's Department of Veterinary Medicine. Their initial focus was on addressing digital dermatitis, a painful condition that affects a significant percentage of cows, leading to both animal suffering and financial losses for farmers. This research prompted the team to create a protective solution that outperforms conventional methods.

Industry Overview

The livestock sector is a vital part of economy in the UK, Ireland, and Europe, characterized by a growing demand for sustainable and effective animal health solutions. The industry faces numerous challenges, including the rise of ant

View Source

Similar Deals

Cornerstone Gladys

2025

Seed Stage Home Healthcare Services United Kingdom
Sofinnova Partners Forth Therapeutics

2025

Seed Stage Bio Therapeutic Drugs United Kingdom
Lifted Ventures Anya

2025

Seed Stage Healthcare Facilities & Services (NEC) United Kingdom
redalpine, IQ Capital Partners, Seedcamp DaltonTx

2025

Seed Stage Proprietary & Advanced Pharmaceuticals United Kingdom
Access EIS MindSpire

2025

Seed Stage Alternative Medicine Facilities United Kingdom
Calculus Capital Laverock Therapeutics

2025

Seed Stage Bio Therapeutic Drugs United Kingdom

The Yield Lab

invested in

NoBACZ Healthcare

in 2025

in a Seed Stage deal

Disclosed details

Transaction Size: $6M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert